Search

Financial results - GENESIS BIOPHARMA ROMANIA SRL

0.00
Financial Summary - Genesis Biopharma Romania Srl
Unique identification code: 37039735
Registration number: J40/1541/2017
Nace: 4646
Sales - Ron
1.852.759
Net Profit - Ron
5.193
Employees
6
Open Account
Company Genesis Biopharma Romania Srl with Fiscal Code 37039735 recorded a turnover of 2024 of 1.852.759, with a net profit of 5.193 and having an average number of employees of 6. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Genesis Biopharma Romania Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 528.710 911.799 1.095.159 887.618 812.060 1.258.768 1.636.765 1.852.759
Total Income - EUR - - 539.047 920.311 1.106.694 899.070 815.661 1.265.067 1.683.178 1.858.088
Total Expenses - EUR - - 497.998 892.954 1.058.943 852.917 774.816 1.201.710 1.612.751 1.778.194
Gross Profit/Loss - EUR - - 41.049 27.357 47.751 46.153 40.845 63.357 70.427 79.894
Net Profit/Loss - EUR - - 11.697 18.174 39.153 29.636 33.673 27.879 5.088 5.193
Employees - - 5 7 7 6 5 6 6 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 13.8%, from 1.636.765 euro in the year 2023, to 1.852.759 euro in 2024. The Net Profit increased by 133 euro, from 5.088 euro in 2023, to 5.193 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Genesis Biopharma Romania Srl

Rating financiar

Financial Rating -
GENESIS BIOPHARMA ROMANIA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Genesis Biopharma Romania Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Genesis Biopharma Romania Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Genesis Biopharma Romania Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Genesis Biopharma Romania Srl - CUI 37039735

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 33.321 28.295 21.997 21.878 27.342 34.086 33.892 28.716
Current Assets - - 111.892 137.699 159.150 165.539 244.010 294.953 331.103 399.097
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 27.370 66.160 112.561 150.213 185.639 257.235 210.817 252.237
Cash - - 84.521 71.539 46.588 15.326 58.371 37.718 120.286 146.860
Shareholders Funds - - 21.548 39.327 77.718 105.881 137.206 165.511 170.097 174.339
Social Capital - - 9.851 9.670 9.483 9.303 9.097 9.125 9.097 9.046
Debts - - 126.353 126.722 32.010 18.706 71.715 54.846 47.604 73.089
Income in Advance - - 0 0 0 0 0 680 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 399.097 euro in 2024 which includes Inventories of 0 euro, Receivables of 252.237 euro and cash availability of 146.860 euro.
The company's Equity was valued at 174.339 euro, while total Liabilities amounted to 73.089 euro. Equity increased by 5.193 euro, from 170.097 euro in 2023, to 174.339 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Genesis Biopharma Romania Srl

Comments - Genesis Biopharma Romania Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.